{"id":912091,"date":"2025-11-20T08:24:13","date_gmt":"2025-11-20T13:24:13","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/"},"modified":"2025-11-20T08:24:13","modified_gmt":"2025-11-20T13:24:13","slug":"shattuck-labs-to-participate-in-upcoming-december-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/","title":{"rendered":"Shattuck Labs to Participate in Upcoming December Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>AUSTIN, TX and DURHAM, NC, Nov.  20, 2025  (GLOBE NEWSWIRE) &#8212; Shattuck Labs, Inc. (\u201cShattuck\u201d or the \u201cCompany\u201d) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today announced that Company management will participate in multiple investor conferences in December 2025.<\/p>\n<p>\n        <strong>Conference Details<\/strong>\n      <\/p>\n<p>\n        <strong>Conference: <\/strong>Piper Sandler 37<sup>th<\/sup> Annual Healthcare Conference<br \/><strong>Format: <\/strong>Presentation and one-on-one meetings<br \/><strong>Presenter: <\/strong>Taylor Schreiber, M.D., Ph.D., Chief Executive Officer<br \/><strong>Presentation Date: <\/strong>Dec 2, 2025<br \/><strong>Time: <\/strong>10:10 AM EST<br \/><strong>Location:<\/strong> New York, NY<br \/><strong>Webcast link: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZiNm4uJowCeW1qL0HXNQbhiahP0dJjBxPdfxjUnJFNJ-QeiXifedEfsBdZHRLomFas0DJZhD49uO5Pln6yJSPn79eJ4cf6JCh_rPivXipnlDOkSMegid7F7ewyUrJ-xPWacFIShAfaRWgWrHihGqTQ==\" rel=\"nofollow\" target=\"_blank\"><strong>HERE<\/strong><\/a><\/p>\n<p>\n        <strong>Conference: <\/strong>Evercore ISI 8<sup>th<\/sup> Annual HealthCONx Conference<br \/><strong>Format: <\/strong>Fireside chat with Umer Raffat and Jonathan Miller, Ph.D. and one-on-one meetings (Dec 3-4)<br \/><strong>Presenter: <\/strong>Taylor Schreiber, M.D., Ph.D., Chief Executive Officer<br \/><strong>Fireside Chat Date: <\/strong>Dec 4, 2025<br \/><strong>Time: <\/strong>8:20 AM EST<br \/><strong>Location:<\/strong> Coral Gables, FL<br \/><strong>Webcast link: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZiNm4uJowCeW1qL0HXNQbgPib2tvpfEju4KGloJMd1BGX2--WIOa_7XqAvZhOEMN3dGZQyv-pAbTi3XuGQbzVTmW-9jDTcC7F7tkwbpG_ZmWU7_IaMJrwpJxLW8i3Z1GEzuANH0M7Q5KURTlC4zDqY1AGybN4KTqlOxGzMSiRAwF93mbHaTUcsO6tUf40F5Es9c4bRNtLh9kAtFm5Txt2g==\" rel=\"nofollow\" target=\"_blank\"><strong>HERE<\/strong><\/a><\/p>\n<p>A replay of the presentations from the Piper Sandler 37<sup>th<\/sup> Annual Healthcare Conference and the Evercore ISI 8<sup>th<\/sup> Annual HealthCONx Conference will be available on the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Y5lzUsoMUy1KjVyMddYV3eO2QHOiX5KELOA9MP4sTWxyiPCZBu1AEbxRJWsRsOFPpEAWstbiggDErt4bpcid-3zM8iDnBSRSzWxduiHsX24vhNS7ekltYFPiAKWdUs2LXrqoG5iycGktFjcdNnaDAWABtccquHuOaD13BWNTj4j82cKTCOvRmqsq_YjfHUKTWUPDK4G34N-wlZbbWemwFwR7cUKH8PSjC1aIPbsnGQLj5zwW7mCRiMk94RKM_JOiEedcfOWBv2lYla07UA-XuJcZxKdhIX33tSDBlMIwZzolcGMDGBFHiAv9oAWiuCeOy-KTiA505hzryQLGyIgZDpxXb-x33i9TytfmTlE8MEWqiiYeV5VGbIUJB15lM7eC\" rel=\"nofollow\" target=\"_blank\">Events and Presentations<\/a>\u00a0section of the Company\u2019s website. A replay of the webcasts will remain archived for up to 30 days following the presentation date.<\/p>\n<p>\n        <strong>About SL-325<\/strong>\n      <\/p>\n<p>SL-325 is a potential first-in-class Death Receptor 3 (DR3) blocking antibody designed to achieve a complete and durable blockade of the clinically validated DR3\/TL1A pathway. Shattuck\u2019s preclinical studies demonstrate high affinity binding and superior activity over TL1A antibodies and offer a data-driven rationale for targeting the TNF receptor, DR3, versus its ligand, TL1A. SL-325 is a fully Fc-silenced humanized immunoglobin G monoclonal antibody with a favorable safety profile in non-human primates, currently being evaluated in a Phase 1 clinical trial.<\/p>\n<p>\n        <strong>About Shattuck Labs, Inc.<\/strong><br \/>\n        <br \/>Shattuck Labs, Inc. (Nasdaq: STTK) is a clinical-stage biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. The Company is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. Shattuck\u2019s expertise in protein engineering and the development of novel TNF receptor therapeutics come together in its lead program, SL-325, a potentially first-in-class DR3 antagonist antibody designed to achieve a more complete blockade of the clinically validated DR3\/TL1A pathway. The Company has offices in both Austin, Texas and Durham, North Carolina. For more information, please visit:\u202fwww.ShattuckLabs.com.<\/p>\n<p>\n        <strong>Investor &amp; Media Contact:<\/strong><br \/>\n        <br \/>Andrew R. Neill<br \/>Chief Financial Officer<br \/>Shattuck Labs, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M4_XzFeqZY2N0SJK0RyfnxzVffWbj1zwJ27liSvww5MPx26tbkH9oMxaYhWTqJgjVlkYmmDTp205jGYICd0QgVRN0IUf2cVdGyUw5h7yoQnjEIlXyqYz1RrkFUdqVoeJrWvLh0ViyXR5FFXvbbCYSQ==\" rel=\"nofollow\" target=\"_blank\">InvestorRelations@shattucklabs.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTIwOSM3Mjc0MDYwIzIyMDI4MzE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NTg2MWI2MjAtZDIxOS00Njc5LWJiMDAtNDVjZWUwMjhjOThkLTEyMTQzODQtMjAyNS0xMS0yMC1lbg==\/tiny\/Shattuck-Labs-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>AUSTIN, TX and DURHAM, NC, Nov. 20, 2025 (GLOBE NEWSWIRE) &#8212; Shattuck Labs, Inc. (\u201cShattuck\u201d or the \u201cCompany\u201d) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today announced that Company management will participate in multiple investor conferences in December 2025. Conference Details Conference: Piper Sandler 37th Annual Healthcare ConferenceFormat: Presentation and one-on-one meetingsPresenter: Taylor Schreiber, M.D., Ph.D., Chief Executive OfficerPresentation Date: Dec 2, 2025Time: 10:10 AM ESTLocation: New York, NYWebcast link: HERE Conference: Evercore ISI 8th Annual HealthCONx ConferenceFormat: Fireside chat with Umer Raffat and Jonathan Miller, Ph.D. and one-on-one meetings (Dec 3-4)Presenter: Taylor Schreiber, M.D., Ph.D., Chief Executive &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Shattuck Labs to Participate in Upcoming December Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-912091","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shattuck Labs to Participate in Upcoming December Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shattuck Labs to Participate in Upcoming December Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, TX and DURHAM, NC, Nov. 20, 2025 (GLOBE NEWSWIRE) &#8212; Shattuck Labs, Inc. (\u201cShattuck\u201d or the \u201cCompany\u201d) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today announced that Company management will participate in multiple investor conferences in December 2025. Conference Details Conference: Piper Sandler 37th Annual Healthcare ConferenceFormat: Presentation and one-on-one meetingsPresenter: Taylor Schreiber, M.D., Ph.D., Chief Executive OfficerPresentation Date: Dec 2, 2025Time: 10:10 AM ESTLocation: New York, NYWebcast link: HERE Conference: Evercore ISI 8th Annual HealthCONx ConferenceFormat: Fireside chat with Umer Raffat and Jonathan Miller, Ph.D. and one-on-one meetings (Dec 3-4)Presenter: Taylor Schreiber, M.D., Ph.D., Chief Executive &hellip; Continue reading &quot;Shattuck Labs to Participate in Upcoming December Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-20T13:24:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTIwOSM3Mjc0MDYwIzIyMDI4MzE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Shattuck Labs to Participate in Upcoming December Investor Conferences\",\"datePublished\":\"2025-11-20T13:24:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\\\/\"},\"wordCount\":411,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3OTIwOSM3Mjc0MDYwIzIyMDI4MzE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\\\/\",\"name\":\"Shattuck Labs to Participate in Upcoming December Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3OTIwOSM3Mjc0MDYwIzIyMDI4MzE=\",\"datePublished\":\"2025-11-20T13:24:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3OTIwOSM3Mjc0MDYwIzIyMDI4MzE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3OTIwOSM3Mjc0MDYwIzIyMDI4MzE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shattuck Labs to Participate in Upcoming December Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shattuck Labs to Participate in Upcoming December Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Shattuck Labs to Participate in Upcoming December Investor Conferences - Market Newsdesk","og_description":"AUSTIN, TX and DURHAM, NC, Nov. 20, 2025 (GLOBE NEWSWIRE) &#8212; Shattuck Labs, Inc. (\u201cShattuck\u201d or the \u201cCompany\u201d) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today announced that Company management will participate in multiple investor conferences in December 2025. Conference Details Conference: Piper Sandler 37th Annual Healthcare ConferenceFormat: Presentation and one-on-one meetingsPresenter: Taylor Schreiber, M.D., Ph.D., Chief Executive OfficerPresentation Date: Dec 2, 2025Time: 10:10 AM ESTLocation: New York, NYWebcast link: HERE Conference: Evercore ISI 8th Annual HealthCONx ConferenceFormat: Fireside chat with Umer Raffat and Jonathan Miller, Ph.D. and one-on-one meetings (Dec 3-4)Presenter: Taylor Schreiber, M.D., Ph.D., Chief Executive &hellip; Continue reading \"Shattuck Labs to Participate in Upcoming December Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-20T13:24:13+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTIwOSM3Mjc0MDYwIzIyMDI4MzE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Shattuck Labs to Participate in Upcoming December Investor Conferences","datePublished":"2025-11-20T13:24:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/"},"wordCount":411,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTIwOSM3Mjc0MDYwIzIyMDI4MzE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/","name":"Shattuck Labs to Participate in Upcoming December Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTIwOSM3Mjc0MDYwIzIyMDI4MzE=","datePublished":"2025-11-20T13:24:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTIwOSM3Mjc0MDYwIzIyMDI4MzE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTIwOSM3Mjc0MDYwIzIyMDI4MzE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shattuck-labs-to-participate-in-upcoming-december-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Shattuck Labs to Participate in Upcoming December Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/912091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=912091"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/912091\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=912091"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=912091"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=912091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}